DiabetesSource

Blood pressure medications address the causes of hypertension and work by different mechanisms to affect blood vessel pressure. They have been proven to lower the risk of cardiovascular incidents, decrease kidney damage, and help patients feel and function better.

Accupril® (quinapril hydrochloride) Tablets Pfizer, Inc. ACE inhibitor indicated for the treatment of hypertension. Recommended initial dosage (in patients not on diuretics): 10mg or 20mg once daily. Usual ...More
ADALAT® CC (nifedipine) Bayer HealthCare ADALAT® CC (nifedipine) is a calcium channel blocker nifedipine, indicated for the treatment of hypertension, in extended-release tablet form. Recommended ...More
ATACAND (candesartan cilexetil) AstraZeneca Pharmaceuticals LP ATACAND (candesartan cilexetil) is a selective AT1 subtype angiotensin II receptor antagonist indicated for the treatment of hypertension. Recommeded ...More
AVAPRO® (irbesartan) Tablets Bristol-Myers Squibb AVAPRO® (irbesartan) Tablets is an ARB antagonist indicated for the treatment of hypertension. Recommended initial dose: 150-300mg once daily. Active ...More
Benicar HCT™ (olmesartan medoxomil and hydrochlorothiazide) Tablets Daiichi Sankyo, Inc. Benicar HCT™ (olmesartan medoxomil and hydrochlorothiazide) Tablets is a combination of an ARB (olmesartan medoxomil) and a thiazide diuretic ...More
Benicar® (olmesartan medoxomil) Tablets Daiichi Sankyo, Inc. Benicar® (olmesartan medoxomil) Tablets is an angiotensin receptor blocker. Usual recommended starting dose: 20mg once daily. Can be increased to 40mg. ...More
CARDENE® SR (nicardipine hydrochloride) Sustatined Release Capsules Roche Laboratories, Inc. Sustained release formulation of CARDENE®, a calcium ion influx inhibitor indicated for the treatment of hypertension. Initial dose: 30mg twice daily. ...More
CARDIZEM® LA (diltiazem hydrochloride) Extended Release Tablets Abbott Laboratories CARDIZEM® LA (diltiazem hydrochloride) Extended Release Tablets is a calcium channel blocker indicated for the treatment of hypertension and management of ...More
CARDURA® (doxazosin mesylate) Tablets Pfizer, Inc. CARDURA® (doxazosin mesylate) Tablets is a selective inhibitor of the alpha1 subtype of alpha adrenergic receptors indicated for the treatment of ...More
Catapres-TTS® (clonidine) Boehringer Ingelheim Pharmaceuticals Catapres-TTS® (clonidine) is a transdermal system providing continuous systemic delivery of clonidine for seven days at an approximately constant rate. ...More
COREG CR™ (cardevilol phosphate) Extended-Release Capsules GlaxoSmithKline COREG CR™ (cardevilol phosphate) Extended-Release Capsules is an extended-release capsule intended for once-daily administration in the treatment of ...More
COREG® (carvedilol) Tablets GlaxoSmithKline COREG® (carvedilol) Tablets is an alpha/beta-adrenergic blocking agent indicated for the treatment of hypertension. Recommended starting dose: 6.25 mg twice ...More
COZAAR® (losartan potassium) Tablets Merck & Co. COZAAR® (losartan potassium) Tablets are AT1 antagonists indicated for the treatment of hypertension. Recommended initial dose: 50mg once daily. Active ...More
Dilacor XR® (diltiazem hyphochloride) Watson Pharmaceuticals, Inc. Dilacor XR® (diltiazem hyphochloride) is an extended-release, orally administered calcium channel blocker used in the treatment of hypertension. Recommended ...More
Diovan® (valsartan) Tablets Novartis Pharmaceuticals Corporation Diovan® (valsartan) Tablets is an angiotensin II receptor blocker (selective for AT1 subtype) indicated for the treatment of hypertension. Recommended ...More
Lotensin® (benazepril hydrochloride) Tablets Novartis Pharmaceuticals Corporation Lotensin® (benazepril hydrochloride) Tablets are ACE inhibitors indicated for the treatment of hypertension. Recommend initial dose: 10mg once daily (for ...More
MAVIK® (trandolapril) Tablets Abbott Laboratories MAVIK® (trandolapril) Tablets are a prescription ACE-inhibitor indicated for the treatment of hypertension and in heart failure post-myocardial infarction ...More
Micardis® (telmisartan) Boehringer Ingelheim Pharmaceuticals Micardis® (telmisartan) is a selective AT1 angiotensin II receptor antagonist indicated for the treatment of hypertension. Usual initial dose: 40mg once ...More
Micardis® HCT (telmisartan and hydrochlorothiazide) Boehringer Ingelheim Pharmaceuticals Micardis® HCT (telmisartan and hydrochlorothiazide) is a combination of telmisartan, an orally active selective AT1 angiotensin II receptor blocker, and ...More
Minipress® (prazosin hydrochloride) Capsules Pfizer, Inc. Minipress® (prazosin hydrochloride) Capsules are indicated in the treatment of hypertension. Can be used alone or in combination with other ...More
MONOPRIL® (fosinopril sodium) Tablets Bristol-Myers Squibb MONOPRIL® (fosinopril sodium) Tablets are ACE inhibitors indicated for the treatment of hypertension. Recommended initial dose: 10mg once daily. Usual ...More
Plendil® (felodipine) AstraZeneca Pharmaceuticals LP Plendil® (felodipine) is a calcium channel blocker indicated for the treatment of hypertension. Recommended starting dose: 5mg once daily. Recommended ...More
PRINIVIL® (lisinopril) Tablets Merck & Co. PRINIVIL® (lisinopril) Tablets are orally administered, long-acting, angiotensin-converting enzyme inhibitors. Recommended initial dose: 10mg once daily. ...More
PROCARDIA XL® (nifedipine) Extended Release Tablets Pfizer, Inc. PROCARDIA XL® (nifedipine) Extended Release Tablets are extended release anti-anginal drug containing calcium channel blockers indicated for the management ...More
PROCARDIA® (nifedipine) Capsules Pfizer, Inc. PROCARDIA® (nifedipine) Capsules are anti-anginal drugs containing calcium channel blockers indicated for the management of vasospastic angina. Recommended ...More
SULAR® (nisoldipine) Sciele Pharma, Inc. SULAR® (nisoldipine) is an extended-release calcium channel blocker indicated for the treatment of hypertension. Usual initial dosage: 20mg. Usual ...More
Tarka® (trandolapril/verapamil ER tablets) Abbott Laboratories Tarka® (trandolapril/verapamil ER tablets) is a combination ACE-inhibitor and calcium channel blocker indicated for the treatment of hypertension, but not ...More
TEVETEN® (eprosartan mesylate) Abbott Laboratories TEVETEN® (eprosartan mesylate) is an ARB indicated for the treatment of hypertension. Usual recommended starting dose is 600mg once daily when used as ...More
TEVETEN® HCT (eprosartan mesylate/hydrochlorothiazide) Abbott Laboratories TEVETEN® HCT (eprosartan mesylate/hydrochlorothiazide) is a combined ARB and diuretic (hydrochlorothiazide) indicated for the treatment of hypertension. ...More
Trandate® (labetalol hydrochloride) Tablets Prometheus Laboratories Inc. Trandate® (labetalol hydrochloride) Tablets are adrenergic receptor-blocking agents that has both selective alpha-adrenergic and non-selective ...More
Zestril® (lisinopril) AstraZeneca Pharmaceuticals LP Zestril® (lisinopril) is an ACE-inhibitor indicated for the treatment of hypertension. Recommended initial dose: 10mg once daily. Usual dosage range: 20 to ...More